TDP-43 acetylation as a pathogenic modification in ALS & related proteinopathies
TDP-43 acetylation as a pathogenic modification in ALS & related proteinopathies
批准号:
8849550
负责人:
Todd Jonathan Cohen
金额:
$24.9万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-15 至 2017-05-31
关键词:
AcetylationAdultAgeAlzheimer&aposs DiseaseAmyotrophic Lateral SclerosisBindingBiologicalBiological MarkersBiologyBrainCell NucleusCellsDNADNA-Binding ProteinsDeacetylaseDementiaDiseaseDisease ProgressionFrontotemporal Lobar DegenerationsFutureGene TargetingGenomicsGoalsHumanIn VitroIndividualLaboratoriesLinkMentorsModificationMotor Neuron DiseaseMotor NeuronsMusNerve DegenerationNeurodegenerative DisordersNeuronsNuclear RNAOnset of illnessPathogenesisPathologyPatientsPharmaceutical PreparationsPhasePhenotypePilot ProjectsPost-Translational Protein ProcessingProteinsRNAResearchResearch PersonnelRoleSkeletal MuscleSpinal CordSurvival RateTauopathiesTechniquesTestingTissuesToxic effectTrainingTransgenic Miceabstractingbaseeffective therapyinnovationinsightloss of functionmouse modelneurofibrillary tangle formationneuropathologynovelprogressive neurodegenerationprotein TDP-43tau Proteinstherapeutic targettreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
7.¿¿Project¿Summary/Abstract¿¿
¿
Amyotrophic¿ Lateral¿ Sclerosis¿ (ALS)¿ is¿ a¿ devastating¿ motor¿ neuron¿ disease¿ with¿ a¿ 3¿5¿ year¿
survival¿ rate¿ and¿ no¿ disease¿modifying¿ therapies.¿ TAR¿ DNA¿binding¿ protein¿ of¿ 43kD¿ (TDP¿43)¿ is¿ a¿
nuclear¿ RNA¿ and¿ DNA¿ binding¿ protein¿ that¿ becomes¿ abnormally¿ aggregated¿ in¿ the¿ brain¿ and¿ spinal¿
cord¿of¿most¿ALS¿patients¿as¿well¿as¿a¿subset¿of¿dementia¿patients¿(frontotemporal¿lobar¿degeneration¿
with¿ TDP¿43¿ pathology,¿ or¿ FTLD¿TDP),¿ placing¿ ALS¿ and¿ FTLD¿TDP¿ within¿ a¿ spectrum¿ of¿ diseases¿
known¿as¿TDP¿43¿proteinopathies.¿¿Although¿TDP¿43¿pathology¿has¿been¿implicated¿in¿disease¿onset¿
and¿ progression,¿ little¿ is¿ known¿ about¿ how¿ TDP¿43¿ becomes¿ aggregated¿ leading¿ to¿ progressive¿
neurodegeneration.¿¿My¿long¿term¿goal¿is¿to¿uncover¿the¿pathogenic¿mechanisms¿that¿promote¿TDP¿43¿
aggregation,¿which¿will¿provide¿insights¿for¿future¿therapies¿against¿these¿debilitating¿diseases.¿¿
Post¿translational¿ modifications¿ have¿ been¿ implicated¿ in¿ the¿ progression¿ of¿ neurodegenerative¿
diseases.¿¿Using¿my¿background¿in¿acetylation¿biology,¿I¿previously¿demonstrated¿that¿acetylation¿of¿the¿
tau¿ protein¿ promotes¿ tangle¿ formation¿ in¿ Alzheimers¿ disease¿ and¿ related¿ tauopathies¿ (Nat¿ Commun.¿
2011~2:252).¿¿I¿have¿now¿demonstrated¿that¿TDP¿43¿is¿subject¿to¿acetylation,¿thus¿highlighting¿a¿new¿
TDP¿43¿ modification¿ that¿ is¿ potentially¿ linked¿ to¿ ALS¿ and¿ related¿ proteinopathies.¿ ¿ The¿ central¿
hypothesis¿ of¿ this¿ proposal¿ is¿ to¿ determine¿ whether¿ acetylation¿ of¿ TDP¿43¿ promotes¿ aggregation¿ and¿
neurodegeneration.¿ To¿ accomplish¿ this¿ goal,¿ I¿ will¿ acquire¿ expertise¿ in¿ neuropathology¿ from¿ the¿
mentoring¿ laboratory¿ and¿ analyze¿ TDP¿43¿ acetylation¿ in¿ ALS¿ and¿ FTLD¿TDP¿ post¿mortem¿ brain¿ and¿
spinal¿ cord¿ as¿ well¿ as¿ TDP¿43¿ transgenic¿ mice¿ characterized¿ by¿ TDP¿43¿ pathology¿ and¿
neurodegeneration.¿ To¿ directly¿ determine¿ whether¿ acetylated¿ TDP¿43¿ promotes¿ disease,¿ primary¿
neuronal¿cultures¿and¿transgenic¿mice¿expressing¿acetylated¿TDP¿43¿will¿be¿evaluated¿for¿pathological¿
hallmarks,¿ toxicity,¿ and¿ neurodegeneration¿ that¿ recapitulate¿ human¿ TDP¿43¿ proteinopathies.¿ Having¿
established¿the¿disease¿relevance¿of¿TDP¿43¿acetylation,¿the¿independent¿phase¿will¿utilize¿in¿vitro¿and¿
cell¿based¿approaches¿to¿investigate¿the¿biological¿significance¿of¿acetylation¿in¿causing¿impaired¿TDP¿
43¿binding¿to¿target¿genes¿and¿RNAs,¿leading¿to¿a¿TDP¿43¿loss¿of¿function.¿¿Finally,¿as¿an¿independent¿
investigator,¿I¿will¿utilize¿K99¿phase¿training¿in¿neurodegenerative¿disease¿to¿generate¿a¿mouse¿model¿
of¿ hyper¿acetylated¿ TDP¿43¿ and¿ determine¿ the¿ ALS¿ phenotype¿ in¿ both¿ brain¿ and¿ skeletal¿ muscle.¿¿
These¿ innovative¿ studies¿ will¿ highlight¿ TDP¿43¿ acetylation¿ as¿ a¿ critical¿ modification¿ linked¿ to¿ the¿
progression¿of¿ALS¿and¿related¿TDP¿43¿proteinopathies.¿
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying kinase signaling pathways linked to tau-mediated neurodegeneration
-
批准号:10753257
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2023
-
负责人:Todd Jonathan Cohen
-
依托单位:
CRISPR gene therapies targeting tau in Alzheimer's disease and tauopathies
-
批准号:10752745
-
项目类别:
-
资助金额:$42.41万
-
财政年份:2023
-
负责人:Todd Jonathan Cohen
-
依托单位:
Sleep-dependent synaptic homeostasis in Alzheimer's disease
-
批准号:10209327
-
项目类别:
-
资助金额:$210.65万
-
财政年份:2021
-
负责人:Todd Jonathan Cohen
-
依托单位:
Identifying Alzheimer’s Disease Causal Variants and Target Genes Using iPSC-derived Microglia
-
批准号:10382389
-
项目类别:
-
资助金额:$73.88万
-
财政年份:2020
-
负责人:Todd Jonathan Cohen
-
依托单位:
Identifying Alzheimer’s Disease Causal Variants and Target Genes Using iPSC-derived Microglia
-
批准号:10615602
-
项目类别:
-
资助金额:$72.23万
-
财政年份:2020
-
负责人:Todd Jonathan Cohen
-
依托单位:
Dual CHIP Functions Control Tau Triage In Alzheimer's Disease
-
批准号:10088361
-
项目类别:
-
资助金额:$61.97万
-
财政年份:2019
-
负责人:Todd Jonathan Cohen
-
依托单位:
Dual CHIP Functions Control Tau Triage In Alzheimer's Disease
-
批准号:10319914
-
项目类别:
-
资助金额:$61.97万
-
财政年份:2019
-
负责人:Todd Jonathan Cohen
-
依托单位:
Dual CHIP Functions Control Tau Triage In Alzheimer's Disease
-
批准号:10539271
-
项目类别:
-
资助金额:$61.97万
-
财政年份:2019
-
负责人:Todd Jonathan Cohen
-
依托单位:
Elucidating The Aberrant TDP-43 Species That Promote Neurodegeneration
-
批准号:10385722
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2018
-
负责人:Todd Jonathan Cohen
-
依托单位:
TDP-43 acetylation as a pathogenic modification in ALS & related proteinopathies
-
批准号:8862550
-
项目类别:
-
资助金额:$24.36万
-
财政年份:2014
-
负责人:Todd Jonathan Cohen
-
依托单位:
TDP-43 acetylation as a pathogenic modification in ALS & related proteinopathies
-
批准号:8425349
-
项目类别:
-
资助金额:$7.44万
-
财政年份:2012
-
负责人:Todd Jonathan Cohen
-
依托单位:
TDP-43 acetylation as a pathogenic modification in ALS & related proteinopathies
-
批准号:8550549
-
项目类别:
-
资助金额:$7.44万
-
财政年份:2012
-
负责人:Todd Jonathan Cohen
-
依托单位:
海外基金